U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

A late-stage trial shows a daily pill helped people lose 12% of their body weight—without injections. Nine teens arrested ...

Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip ...

Novo Nordisk stock gains as FDA expands Wegovy use, while Ozempic price cut aims to boost access and defend market share.

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

A firm led by Irish motor dealer Eugene O’Reilly has bought a 25 per cent stake... Eli Lilly & Co. is tapping the US investment-grade debt market with a deal that’s... Novo Nordisk is slashing the ...

Sanjeev Gupta is lining up financing from BlackRock for a contentious scheme to buy... Berenberg, the European private bank, has raised its price target for building materials ...